Investigation of plasma remifentanil elimination rate and improvement of safety

Investigation of plasma remifentanil elimination rate and improvement of safety - Measurement of Remifentanil blood concentration

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009304

Enrollment

Registered

2012-11-10

Start date

2009-02-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent sceduled operation under general anesthesia using remifentanil

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent sceduled operation under general anesthesia using remifentanil

Exclusion criteria

Exclusion criteria: Patients who have severe cardiovascular disease or severe anemia

Design outcomes

Primary

Measure	Time frame
Assesment of remifentanil blood concentrations at 0,1,3,5,7,10,15,20 and 30 min after termination of remifentanil infusion at 0.2 mcg/kg/min	—

Countries

Japan

Contacts

Public ContactTomoyuki Kudo

Hirosaki University Graduate School of Medicine Department of Anesthesiology

0172-33-5113

Outcome results